Soluble biglycan as a biomarker of inflammatory renal diseases.
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansOncosuppressive functions of decorinDecoding the Matrix: Instructive Roles of Proteoglycan ReceptorsInsights into the key roles of proteoglycans in breast cancer biology and translational medicineDecorin as a multivalent therapeutic agent against cancer.Biglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants.Complexity of danger: the diverse nature of damage-associated molecular patterns.Advances in Toll-like receptor biology: Modes of activation by diverse stimuli.Inflammasomes in the urinary tract: a disease-based review.Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia.Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway.Urothelial cancer proteomics provides both prognostic and functional information.Small Leucine-Rich Proteoglycans in Renal Inflammation: Two Sides of the Coin.Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition.Damage-associated molecular patterns and their role as initiators of inflammatory and auto-immune signals in systemic lupus erythematosus.Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity.
P2860
Q21710680-28DD9CD6-610D-49C8-A4A1-869CE4E8E898Q26745697-8DD0DEFA-873F-43C7-AE3F-D30ACF2EEED4Q26801397-D0DB89C0-511E-43F8-B209-D7B5B75946D0Q28085548-B2C4D7A6-690B-4285-9CCB-415124104B31Q36578803-CC8E1689-ADD2-4EC2-9A5C-6E612635B30CQ37729228-EE8CBA53-043D-45F0-A5DB-DAD5204C806EQ38267715-F20B42FC-80EC-4E62-B18F-F005BE5B1D87Q38413291-18CE3150-6A10-4F0F-AD5A-C97652852AC0Q38832656-3295CDEC-8DB7-473A-A26F-962046A3138EQ39012517-8DBA8D90-7B22-4EF0-BEFE-FAEDC705C599Q39417936-10F7024B-6F14-4488-B55E-473CE6545979Q41827719-DFDE18FE-59B0-49B1-B1F1-4819827F2F53Q47156880-4637AFC1-E24A-44C1-B3B3-9B3C829F0BCCQ47229248-433A51B9-EF88-4C5E-BB1C-240D04ADEEC7Q47768797-D2B7ABF8-3FD4-4E20-B84C-13A5E2B545F3Q48269154-D2DDE123-B164-4EEB-881C-C79931F407DCQ49382014-D54009F6-7751-40F4-9BEB-C94C55C7FD95
P2860
Soluble biglycan as a biomarker of inflammatory renal diseases.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Soluble biglycan as a biomarker of inflammatory renal diseases.
@ast
Soluble biglycan as a biomarker of inflammatory renal diseases.
@en
Soluble biglycan as a biomarker of inflammatory renal diseases.
@nl
type
label
Soluble biglycan as a biomarker of inflammatory renal diseases.
@ast
Soluble biglycan as a biomarker of inflammatory renal diseases.
@en
Soluble biglycan as a biomarker of inflammatory renal diseases.
@nl
prefLabel
Soluble biglycan as a biomarker of inflammatory renal diseases.
@ast
Soluble biglycan as a biomarker of inflammatory renal diseases.
@en
Soluble biglycan as a biomarker of inflammatory renal diseases.
@nl
P2093
P2860
P921
P1476
Soluble biglycan as a biomarker of inflammatory renal diseases.
@en
P2093
Jinyang Zeng-Brouwers
Louise Tzung-Harn Hsieh
Madalina-Viviana Nastase
P2860
P304
P356
10.1016/J.BIOCEL.2014.07.020
P577
2014-08-01T00:00:00Z
2014-09-01T00:00:00Z